Iatrogenic left main coronary artery (LMCA) dissection is an infrequent but potentially feared complication of cardiac catheterization [@bib0005], [@bib0010], [@bib0015]. It is twice as likely to occur during percutaneous coronary intervention (PCI) (0.10%) when compared to diagnostic catheterization (0.06%) [@bib0020]. This life-threatening complication is typically caused by vigorous hand injection of contrast medium, subintimal passage of guidewire, or inadvertent guiding catheter manipulation. The development of intimal tears and propagation of hematoma may be related to an underlying structural weakness of media. Although emergent coronary artery bypass graft surgery (CABG) is the most frequent therapeutic strategy to prevent deteriorating hemodynamic condition and worsening angina, the 30-day mortality rate remains as high as 26% following a successful CABG [@bib0025]. It is a time-consuming procedure that carries the risk of irreversible and extensive myocardial damage. Prompt coronary stent implantation to bailout dissection is a useful option when managing this fatal complication. To cover intracoronary dissection with stents may seal the entry port of LMCA dissection. Intra-aortic balloon pump (IABP) may serve as a hemodynamic support during PCI, but is contraindicated in the presence of concomitant aortic dissection. Percutaneous cardiopulmonary support may be a crucial alternative [@bib0030].

Kuriyama et al. reported a case of intravascular ultrasound (IVUS)-guided bailout for iatrogenic LMCA dissection [@bib0060]. IVUS information was very useful to achieve a guidewire entering into the true lumen in the most perilous complication during PCI. IVUS is a powerful tool in this clinical scenario and ideally should be available with operators trained in its use. Furthermore, IVUS imaging may help to evaluate complete coverage of LMCA dissection, which presumably will prevent further propagation [@bib0035]. This case illustrates the superiority of the images and information obtained with IVUS, which allows the examination of the true lumen, providing valuable information that can guide and prompt appropriate PCI procedures.

The clinical utility of IVUS is a patent fact. The major use of IVUS is to plan PCI strategy and optimize stent deployment [@bib0040]. Pre-PCI IVUS accurately assesses lesion length and reference lumen dimensions for appropriate stent sizing. Identification of superficial calcium can lead to pre-stent rotational atherectomy. Post-stent IVUS assessment may detect complications of PCI and suboptimal stent deployment. The benefit of IVUS-guided PCI is most important in complex lesion subsets, such as LMCA [@bib0045] and bifurcation lesions [@bib0050], where studies suggest that IVUS guidance may reduce mortality. It has been postulated that the mechanism of benefit is related to reduced rates of sudden cardiac death related to late stent thrombosis. In addition, IVUS is useful to assess intermediate coronary artery disease, especially in LMCA. IVUS can also provide insights into the mechanism of stent restenosis. Furthermore, IVUS can detect the development of transplant vasculopathy. These are supported by the American College of Cardiology/American Heart Association PCI guidelines (IIa or IIb indication) ([Table 1](#tbl0005){ref-type="table"}) [@bib0055]. Perivascular IVUS landmarks such as coronary veins, pericardium, myocardium, and side branches are useful to know coronary artery geometry during PCI. In chronic total occlusion lesions, antegrade recanalization approaches often result in subintimal guidewire tracking. IVUS imaging from the false lumen may be useful to guide re-entry of the guidewire into the true lumen. In this case, both aorta and the guidewire in the false lumen were important landmarks to determine the orientation of the entry site of the false lumen of the LMCA dissection. Operators should be trained in its usage and be familiar with precise interpretation of IVUS images.Table 1Indication for intravascular ultrasound.Class IIaAssessment of angiographically indeterminant left main coronary artery disease (level of evidence: B)Assessment of cardiac transplant vasculopathy (level of evidence: B)Determine the mechanism of stent restenosis (level of evidence: C)  Class IIbAssessment of non-left main coronary arteries with angiographically intermediate coronary stenosis (50--70% diameter stenosis) (level of evidence: B)Guidance of coronary stent implantation, particularly in cases of left main coronary artery stenting (level of evidence: B)Determine the mechanism of stent thrombosis (level of evidence: C)  Class IIIRoutine lesion assessment when revascularization with PCI or CABG is not being contemplated (level of evidence: C)[^1]Adapted from 2011 ACC/AHA/SCAI PCI guideline [@bib0055].

[^1]: PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft.
